Anchor Parent, LLC acquires Enhabit, Inc. (2026)

Deal facts

Buyer: Anchor Parent, LLC
Target: Enhabit, Inc.
Deal value: Not disclosed
Announced: 22 February 2026
Status: Completed
Sector: Healthcare
Country: United States
Consideration: cash

Sources

What we know

Anchor Parent, LLC has agreed to acquire Enhabit, Inc. in a going private transaction valued at an undisclosed amount. The deal, announced on 22 February 2026, was executed through a cash consideration structure. Both entities are based in the United States and operate within the healthcare sector. The transaction was completed on 15 May 2026, marking the conclusion of the acquisition process.

The agreement involves the transfer of ownership from public shareholders to the private buyer, effectively delisting the target company from public markets. No specific valuation figures or strategic motivations were disclosed in the available reporting. The deal represents a significant consolidation within the US healthcare landscape, bringing the business under private ownership. The transaction is now fully completed and no further regulatory approvals are required.

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update

15 May 2026CompletedClosed
Anchor Parent, LLC completes acquisition of Enhabit, Inc.
INTRODUCTORY NOTE On May 15, 2026 (the “ Closing Date ”), Anchor Parent, LLC, a Delaware limited liability company (“ Parent ”), completed the previously announced acquisition of Enhabit, Inc., a Delaware corporation (“ Enhabit ” or the “ Company ”), pursuant to the Agreement and Plan of Merger, dated as of February 22, 2026 (the “ Merger Agreement ”), by and among Enhabit, Parent and Anchor Merge
Source

OpinionExit Mode editorial

We see a clear signal in the announcement that Anchor Parent, LLC has acquired Enhabit, Inc. This transaction, completed on 22 February 2026, moves a significant US healthcare operator from public markets into private hands. The deal is structured as a going-private transaction with all-cash consideration. While the specific valuation remains undisclosed, the mechanics are straightforward and decisive. The buyer has chosen to remove the target from public scrutiny entirely, paying in cash rather than relying on stock swaps or complex contingent structures.

For the SME founder watching from across the Atlantic, this deal highlights the enduring appeal of a clean exit in the healthcare sector. The all-cash nature of the consideration removes the uncertainty often associated with earn-outs or deferred payments. It also sidesteps the immediate need for shareholder approval processes that can drag on in public markets, although the buyer must still navigate any applicable US antitrust thresholds given the sector. The absence of a stated price in the public record is common for private equity roll-ups, yet the completed status confirms that both parties agreed on terms that satisfied their respective due diligence requirements. This is a testament to the liquidity available for well-positioned healthcare assets, even when the buyer is a private entity rather than a public corporation.

The strategic implication is a shift from quarterly reporting pressure to long-term operational focus. Enhabit will now operate under the ownership of Anchor Parent without the distraction of public market volatility. This structure often allows for more aggressive investment in service lines or technology that might be scrutinised too heavily by short-term investors. We view this as a pragmatic move for a sector where scale and consistency matter more than quarterly earnings beats. The regulatory context remains stable, with the deal clearing necessary reviews to reach completion.

Our view is that founders should prioritise deal certainty over headline valuation when the buyer offers an all-cash, going-private structure. If you are currently in the market, request a term sheet that specifies cash consideration and a defined closing timeline. Do not accept vague language on payment mechanics or contingent payouts unless you have a robust legal team to draft the specific protections you need. Act on this by asking your advisors to model the net proceeds of an all-cash offer against any deal that includes stock or earn-outs this week.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Healthcare deals More 2026 deals More going private deals More from Anchor Parent, LLC All M&A deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

6 July 2026CompletedHealthcare

Trafalgar Asset Management, LLC to acquire The Greater Cannabis Company, Inc.

Trafalgar Asset Management, LLC has agreed to acquire The Greater Cannabis Company, Inc. in a going private transaction. The deal was announced on 6 July 2026, following…

Buyer: Trafalgar Asset Management, LLC
Target: The Greater Cannabis Company, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United States deals

30 June 2026CompletedHealthcare

Hanmi Pharmaceuticals Co. Ltd. to acquire Aptose Biosciences Inc.

Hanmi Pharmaceuticals Co. Ltd. has agreed to acquire Aptose Biosciences Inc. in a going private transaction valued at USD 3,466,470. The consideration for this deal cons…

Buyer: Hanmi Pharmaceuticals Co. Ltd.
Target: Aptose Biosciences Inc.
Deal value: USD 3,466,470
Deal type: going private

Read deal Healthcare deals going private deals Canada deals

9 June 2026CompletedHealthcare

GlaxoSmithKline LLC to acquire Nuvalent, Inc.

GlaxoSmithKline LLC has agreed to acquire Nuvalent, Inc. in a going private transaction. The deal was announced on 9 June 2026 and completed on 15 July 2026. The conside…

Buyer: GlaxoSmithKline LLC
Target: Nuvalent, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United States deals

3 June 2026CompletedHealthcare

FONAR, LLC to acquire FONAR Corporation

FONAR, LLC has agreed to acquire FONAR Corporation in a going private transaction completed on 3 June 2026. The deal involves the purchase of the US-based healthcare com…

Buyer: FONAR, LLC
Target: FONAR Corporation
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United States deals

13 May 2026CompletedHealthcare

Zydus Worldwide DMCC to acquire Assertio Holdings, Inc.

Zydus Worldwide DMCC has agreed to acquire Assertio Holdings, Inc. in a going private transaction valued at an undisclosed amount. The deal, announced on 13 May 2026, wa…

Buyer: Zydus Worldwide DMCC
Target: Assertio Holdings, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Healthcare deals going private deals United States deals

Buyer history